Chlorpromazine-tadalafil interaction leading to refractory ischemic priapism and penile prosthesis implantation: a case report
Priapism represents a rare urological emergency characterized by persistent penile erection unrelated to sexual stimulation. Although chlorpromazine-induced priapism has been documented, the synergistic interaction with phosphodiesterase type 5 inhibitors resulting in refractory cases necessitating...
Saved in:
Published in | Basic and clinical andrology Vol. 35; no. 1; pp. 30 - 6 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central
14.08.2025
BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Priapism represents a rare urological emergency characterized by persistent penile erection unrelated to sexual stimulation. Although chlorpromazine-induced priapism has been documented, the synergistic interaction with phosphodiesterase type 5 inhibitors resulting in refractory cases necessitating penile prosthesis implantation constitutes a novel clinical scenario requiring comprehensive documentation.
We report a 56-year-old male who developed refractory ischemic priapism following self-administration of oral chlorpromazine for hiccups, taken 24 h after tadalafil 20 mg for erectile dysfunction. The patient had previously experienced a transient priapism episode 10 years earlier following isolated chlorpromazine use, establishing chlorpromazine as the primary etiological agent. Despite comprehensive management including corporal aspiration, intracavernosal sympathomimetic injection, and distal T-shunt creation, the patient developed recurrent priapism requiring penile prosthesis implantation.
This case demonstrates compelling evidence of a dangerous chlorpromazine-tadalafil interaction resulting in treatment-refractory priapism. The synergistic pharmacological effects of alpha-adrenergic blockade and phosphodiesterase type 5 inhibition created a severe clinical presentation necessitating immediate penile prosthesis implantation. Healthcare practitioners must recognize this potentially devastating drug interaction and implement preventive measures through comprehensive medication reconciliation and patient counseling. |
---|---|
AbstractList | Priapism represents a rare urological emergency characterized by persistent penile erection unrelated to sexual stimulation. Although chlorpromazine-induced priapism has been documented, the synergistic interaction with phosphodiesterase type 5 inhibitors resulting in refractory cases necessitating penile prosthesis implantation constitutes a novel clinical scenario requiring comprehensive documentation.BACKGROUNDPriapism represents a rare urological emergency characterized by persistent penile erection unrelated to sexual stimulation. Although chlorpromazine-induced priapism has been documented, the synergistic interaction with phosphodiesterase type 5 inhibitors resulting in refractory cases necessitating penile prosthesis implantation constitutes a novel clinical scenario requiring comprehensive documentation.We report a 56-year-old male who developed refractory ischemic priapism following self-administration of oral chlorpromazine for hiccups, taken 24 h after tadalafil 20 mg for erectile dysfunction. The patient had previously experienced a transient priapism episode 10 years earlier following isolated chlorpromazine use, establishing chlorpromazine as the primary etiological agent. Despite comprehensive management including corporal aspiration, intracavernosal sympathomimetic injection, and distal T-shunt creation, the patient developed recurrent priapism requiring penile prosthesis implantation.CASE PRESENTATIONWe report a 56-year-old male who developed refractory ischemic priapism following self-administration of oral chlorpromazine for hiccups, taken 24 h after tadalafil 20 mg for erectile dysfunction. The patient had previously experienced a transient priapism episode 10 years earlier following isolated chlorpromazine use, establishing chlorpromazine as the primary etiological agent. Despite comprehensive management including corporal aspiration, intracavernosal sympathomimetic injection, and distal T-shunt creation, the patient developed recurrent priapism requiring penile prosthesis implantation.This case demonstrates compelling evidence of a dangerous chlorpromazine-tadalafil interaction resulting in treatment-refractory priapism. The synergistic pharmacological effects of alpha-adrenergic blockade and phosphodiesterase type 5 inhibition created a severe clinical presentation necessitating immediate penile prosthesis implantation. Healthcare practitioners must recognize this potentially devastating drug interaction and implement preventive measures through comprehensive medication reconciliation and patient counseling.CONCLUSIONSThis case demonstrates compelling evidence of a dangerous chlorpromazine-tadalafil interaction resulting in treatment-refractory priapism. The synergistic pharmacological effects of alpha-adrenergic blockade and phosphodiesterase type 5 inhibition created a severe clinical presentation necessitating immediate penile prosthesis implantation. Healthcare practitioners must recognize this potentially devastating drug interaction and implement preventive measures through comprehensive medication reconciliation and patient counseling. Abstract Background Priapism represents a rare urological emergency characterized by persistent penile erection unrelated to sexual stimulation. Although chlorpromazine-induced priapism has been documented, the synergistic interaction with phosphodiesterase type 5 inhibitors resulting in refractory cases necessitating penile prosthesis implantation constitutes a novel clinical scenario requiring comprehensive documentation. Case presentation We report a 56-year-old male who developed refractory ischemic priapism following self-administration of oral chlorpromazine for hiccups, taken 24 h after tadalafil 20 mg for erectile dysfunction. The patient had previously experienced a transient priapism episode 10 years earlier following isolated chlorpromazine use, establishing chlorpromazine as the primary etiological agent. Despite comprehensive management including corporal aspiration, intracavernosal sympathomimetic injection, and distal T-shunt creation, the patient developed recurrent priapism requiring penile prosthesis implantation. Conclusions This case demonstrates compelling evidence of a dangerous chlorpromazine-tadalafil interaction resulting in treatment-refractory priapism. The synergistic pharmacological effects of alpha-adrenergic blockade and phosphodiesterase type 5 inhibition created a severe clinical presentation necessitating immediate penile prosthesis implantation. Healthcare practitioners must recognize this potentially devastating drug interaction and implement preventive measures through comprehensive medication reconciliation and patient counseling. Priapism represents a rare urological emergency characterized by persistent penile erection unrelated to sexual stimulation. Although chlorpromazine-induced priapism has been documented, the synergistic interaction with phosphodiesterase type 5 inhibitors resulting in refractory cases necessitating penile prosthesis implantation constitutes a novel clinical scenario requiring comprehensive documentation. We report a 56-year-old male who developed refractory ischemic priapism following self-administration of oral chlorpromazine for hiccups, taken 24 h after tadalafil 20 mg for erectile dysfunction. The patient had previously experienced a transient priapism episode 10 years earlier following isolated chlorpromazine use, establishing chlorpromazine as the primary etiological agent. Despite comprehensive management including corporal aspiration, intracavernosal sympathomimetic injection, and distal T-shunt creation, the patient developed recurrent priapism requiring penile prosthesis implantation. This case demonstrates compelling evidence of a dangerous chlorpromazine-tadalafil interaction resulting in treatment-refractory priapism. The synergistic pharmacological effects of alpha-adrenergic blockade and phosphodiesterase type 5 inhibition created a severe clinical presentation necessitating immediate penile prosthesis implantation. Healthcare practitioners must recognize this potentially devastating drug interaction and implement preventive measures through comprehensive medication reconciliation and patient counseling. |
ArticleNumber | 30 |
Author | Akbay, Erdem Basaranoglu, Mert Cayan, Selahittin Bozlu, Murat Arici, Can |
Author_xml | – sequence: 1 givenname: Can orcidid: 0009-0000-8034-0571 surname: Arici fullname: Arici, Can – sequence: 2 givenname: Mert orcidid: 0000-0002-9873-4920 surname: Basaranoglu fullname: Basaranoglu, Mert – sequence: 3 givenname: Selahittin orcidid: 0000-0003-4784-2208 surname: Cayan fullname: Cayan, Selahittin – sequence: 4 givenname: Murat orcidid: 0000-0002-8624-0149 surname: Bozlu fullname: Bozlu, Murat – sequence: 5 givenname: Erdem orcidid: 0000-0001-7669-414X surname: Akbay fullname: Akbay, Erdem |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40804624$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkk9v1DAQxS1UREvpF-CAfOQS8L8kNheEVrRUqsQFztZsPNl15djBzqItBz473m6pWl_GGj_9xnrzXpOTmCIS8pazD5zr7mPhouOsYaJtGBO9bvYvyJlgLW8UN-zkyf2UXJRyy-oxRjLNXpFTVYvqhDojf1fbkPKc0wR_fMRmAQcBRh-ojwtmGBafIg0IzscNXRLNOB66Kd9RX4YtTn6gc_Yw-zJRiI7OGH3A2ktl2WLxhfppDhAXOKA-UaADFKycOeXlDXk5Qih48VDPyc_Lrz9W35qb71fXqy83zaCY2jfaMGdaNRgmjWgBkYu1kKD1iN0opQSUoxgYKq64xH50wiDvULtes25spTwn10euS3Br638nyHc2gbf3jZQ3FvLih4BWo-46OXKoHNU5tV5L4apdnBnVox4r6_ORNe_WE7oB45IhPIM-f4l-azfpt-VCtnUfphLePxBy-rXDstipeomhuoRpV6wU0kjTGyWq9N3TYY9T_m-wCsRRMFTDS93Oo4Qze0iKPSbF1qTY-6TYvfwHy6Kzyg |
Cites_doi | 10.1111/andr.13740 10.1038/s41443-025-01078-7 10.1016/j.sxmr.2018.10.007 10.1248/bpb.b25-00083 10.1016/j.juro.2013.07.034 10.5534/wjmh.2016.34.1.1 10.1016/j.sxmr.2020.10.003 10.1038/s41443-022-00592-2 10.1155/2017/7394185 10.4088/PCC.19l02543 10.1093/sxmrev/qeae007 10.1097/JCP.0000000000001940 10.1038/ijir.2014.19 10.1038/s41443-022-00583-3 10.1007/s00120-016-0040-6 10.1016/s0361-1124(77)80171-8 10.1001/jama.2023.13377 10.1007/s13181-019-00719-w |
ContentType | Journal Article |
Copyright | 2025. The Author(s). The Author(s) 2025 2025 |
Copyright_xml | – notice: 2025. The Author(s). – notice: The Author(s) 2025 2025 |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.1186/s12610-025-00278-x |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 2051-4190 |
EndPage | 6 |
ExternalDocumentID | oai_doaj_org_article_8e8663f1ae7f46d4bb32d80410947e8f PMC12351909 40804624 10_1186_s12610_025_00278_x |
Genre | Journal Article |
GroupedDBID | 0R~ 53G 5VS 7X7 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABUWG ACGFS ADBBV ADRAZ ADUKV AFKRA AFPKN AHBYD AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION DIK EBLON EBS EMOBN FYUFA GROUPED_DOAJ HMCUK HYE IAO IHR IHW ITC KQ8 M~E OK1 PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RBZ ROL RPM RSV SOJ UKHRP NPM 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c404x-890d954c903925aee12b23a88fe6f333ae3f2c0e41413e7fd29e16e8d7806f533 |
IEDL.DBID | DOA |
ISSN | 2051-4190 |
IngestDate | Wed Aug 27 01:31:23 EDT 2025 Thu Aug 21 18:25:34 EDT 2025 Thu Aug 14 17:50:38 EDT 2025 Sun Aug 17 02:22:25 EDT 2025 Thu Aug 21 00:03:59 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Penile prosthesis Ischemic priapism Priapism Tadalafil Drug interaction Chlorpromazine |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c404x-890d954c903925aee12b23a88fe6f333ae3f2c0e41413e7fd29e16e8d7806f533 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-8624-0149 0000-0001-7669-414X 0009-0000-8034-0571 0000-0003-4784-2208 0000-0002-9873-4920 |
OpenAccessLink | https://doaj.org/article/8e8663f1ae7f46d4bb32d80410947e8f |
PMID | 40804624 |
PQID | 3239397942 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_8e8663f1ae7f46d4bb32d80410947e8f pubmedcentral_primary_oai_pubmedcentral_nih_gov_12351909 proquest_miscellaneous_3239397942 pubmed_primary_40804624 crossref_primary_10_1186_s12610_025_00278_x |
PublicationCentury | 2000 |
PublicationDate | 20250814 |
PublicationDateYYYYMMDD | 2025-08-14 |
PublicationDate_xml | – month: 8 year: 2025 text: 20250814 day: 14 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Basic and clinical andrology |
PublicationTitleAlternate | Basic Clin Androl |
PublicationYear | 2025 |
Publisher | BioMed Central BMC |
Publisher_xml | – name: BioMed Central – name: BMC |
References | K Shigehara (278_CR3) 2016; 34 LP Ferreira (278_CR9) 2020; 22 N Schifano (278_CR18) 2024 N Schifano (278_CR5) 2024; 36 LC Licari (278_CR1) 2023; 13 H Ueda (278_CR15) 2023; 48 278_CR6 H Choi (278_CR14) 2015; 27 RJ Fantus (278_CR10) 2023; 330 E Zacharakis (278_CR17) 2014; 191 T Hwang (278_CR4) 2021; 9 NA Mistry (278_CR16) 2017; 2017 TE Merkin (278_CR7) 1977; 6 P Capogrosso (278_CR2) 2024; 36 M Capece (278_CR12) 2019; 7 F Inoue (278_CR8) 2023; 45 GA Beauchamp (278_CR13) 2019; 15 M Elmarasi (278_CR11) 2024; 12 |
References_xml | – volume: 13 start-page: 811 issue: 4 year: 2023 ident: 278_CR1 publication-title: Andrology doi: 10.1111/andr.13740 – year: 2024 ident: 278_CR18 publication-title: Int J Impot Res doi: 10.1038/s41443-025-01078-7 – volume: 7 start-page: 530 issue: 3 year: 2019 ident: 278_CR12 publication-title: Sex Med Rev doi: 10.1016/j.sxmr.2018.10.007 – volume: 48 start-page: 713 issue: 5 year: 2023 ident: 278_CR15 publication-title: Biol Pharm Bull doi: 10.1248/bpb.b25-00083 – volume: 191 start-page: 164 issue: 1 year: 2014 ident: 278_CR17 publication-title: J Urol doi: 10.1016/j.juro.2013.07.034 – volume: 34 start-page: 1 issue: 1 year: 2016 ident: 278_CR3 publication-title: World J Mens Health doi: 10.5534/wjmh.2016.34.1.1 – volume: 9 start-page: 464 issue: 3 year: 2021 ident: 278_CR4 publication-title: Sex Med Rev doi: 10.1016/j.sxmr.2020.10.003 – volume: 36 start-page: 6 issue: 1 year: 2024 ident: 278_CR2 publication-title: Int J Impot Res doi: 10.1038/s41443-022-00592-2 – volume: 2017 start-page: 7394185 year: 2017 ident: 278_CR16 publication-title: Case Rep Urol doi: 10.1155/2017/7394185 – volume: 22 start-page: 19l02543 issue: 4 year: 2020 ident: 278_CR9 publication-title: Prim Care Companion CNS Disord doi: 10.4088/PCC.19l02543 – volume: 12 start-page: 528 issue: 3 year: 2024 ident: 278_CR11 publication-title: Sex Med Rev doi: 10.1093/sxmrev/qeae007 – volume: 45 start-page: 54 issue: 1 year: 2023 ident: 278_CR8 publication-title: J Clin Psychopharmacol doi: 10.1097/JCP.0000000000001940 – volume: 27 start-page: 33 issue: 1 year: 2015 ident: 278_CR14 publication-title: Int J Impot Res doi: 10.1038/ijir.2014.19 – volume: 36 start-page: 50 issue: 1 year: 2024 ident: 278_CR5 publication-title: Int J Impot Res doi: 10.1038/s41443-022-00583-3 – ident: 278_CR6 doi: 10.1007/s00120-016-0040-6 – volume: 6 start-page: 367 issue: 8 year: 1977 ident: 278_CR7 publication-title: JACEP doi: 10.1016/s0361-1124(77)80171-8 – volume: 330 start-page: 559 issue: 6 year: 2023 ident: 278_CR10 publication-title: JAMA doi: 10.1001/jama.2023.13377 – volume: 15 start-page: 262 issue: 4 year: 2019 ident: 278_CR13 publication-title: J Med Toxicol doi: 10.1007/s13181-019-00719-w |
SSID | ssj0000993080 |
Score | 2.318236 |
Snippet | Priapism represents a rare urological emergency characterized by persistent penile erection unrelated to sexual stimulation. Although chlorpromazine-induced... Abstract Background Priapism represents a rare urological emergency characterized by persistent penile erection unrelated to sexual stimulation. Although... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 30 |
SubjectTerms | Case Report Chlorpromazine Drug interaction Ischemic priapism Penile prosthesis Priapism Tadalafil |
Title | Chlorpromazine-tadalafil interaction leading to refractory ischemic priapism and penile prosthesis implantation: a case report |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40804624 https://www.proquest.com/docview/3239397942 https://pubmed.ncbi.nlm.nih.gov/PMC12351909 https://doaj.org/article/8e8663f1ae7f46d4bb32d80410947e8f |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pa9swFBZbd9llbOt-eN2CBmOXIWpLsiz31paWskMZY4XchGw9UY_EMXEK6WV_-56kpCRjsMuutkBC37Pe91lPnwj5VDiuaq0cC7mXSV14prVDzVPlTTBQQ9Ybq3yv1dWN_DotpztXfYWasGQPnCbuWIPGpOgLC5WXysmmEdwF0xzUJRVoH1ZfzHk7Yupn4j0CudD2lIxWx2OBWiFn4fbWuNvG1nuZKBr2_41l_lksuZN9Lp-TZxvaSE_TcF-QR9C_JIenPUrm-T39TGMhZ_xDfkh-nd-iCMcu5tE6mq2sszPruxkN3hDLdJKBzlL1PF0tKA5tGa_duacdit1QLk8HDMyhG-fU9o4O0OPigc8WI_LFsRtpNx9mNp1a6k-opS0mQ5r2H16Rm8uLH-dXbHPNAmtlLtdM17mrS9nWOeJVWoCCN1xYrT0oL4SwIDxvc5AFJjxEwfEaCgXaVTpXHunia3LQL3p4S2gjvJWuzUsOSgI2KFvRBsN3C7UQkGfky3bKzZDcNExUIVqZBJBBgEwEyKwzchZQeWgZnLDjA4wPs4kP86_4yMjHLaYGv5ywHWJ7WNyNRgT3txrXI56RNwnjh64kBo9UXGZE76G_N5b9N313G925w-FjZFn1u_8x-iPylMeQRakv35OD1fIOPiALWjUT8riaVhPy5Ozi-tv3SQz_37NhCWs |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chlorpromazine-tadalafil+interaction+leading+to+refractory+ischemic+priapism+and+penile+prosthesis+implantation%3A+a+case+report&rft.jtitle=Basic+and+clinical+andrology&rft.au=Arici%2C+Can&rft.au=Basaranoglu%2C+Mert&rft.au=Cayan%2C+Selahittin&rft.au=Bozlu%2C+Murat&rft.date=2025-08-14&rft.issn=2051-4190&rft.eissn=2051-4190&rft.volume=35&rft.issue=1&rft_id=info:doi/10.1186%2Fs12610-025-00278-x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12610_025_00278_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2051-4190&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2051-4190&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2051-4190&client=summon |